Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume 22, Issue 8, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-18
DOI
10.1007/s11883-020-00858-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia
- (2020) et al. JAMA Cardiology
- Case report: The efficiency and safety of lomitapide in a homozygous familial hypercholesterolemic child
- (2019) Ana Paula M. Chacra et al. Journal of Clinical Lipidology
- Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
- (2019) Tawfeg Ben-Omran et al. ADVANCES IN THERAPY
- A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study
- (2019) Claudia Stefanutti et al. Journal of Clinical Lipidology
- Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia
- (2019) Genovefa Kolovou et al. European Journal of Preventive Cardiology
- Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia
- (2018) Raul D. Santos ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Autosomal recessive hypercholesterolemia in Spain
- (2018) Rosa María Sánchez-Hernández et al. ATHEROSCLEROSIS
- A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
- (2018) Meral Kayikcioglu et al. ATHEROSCLEROSIS
- Lomitapide in homozygous familial hypercholesterolemia
- (2018) Simona Sperlongano et al. Journal of Cardiovascular Medicine
- Long-term liver safety of lomitapide in patients with homozygous familial hypercholesterolemia: Three-year data from the lomitapide observational worldwide evaluation registry (LOWER)
- (2018) D. Larrey et al. JOURNAL OF HEPATOLOGY
- Autosomal Recessive Hypercholesterolemia
- (2018) Laura D’Erasmo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
- (2018) Dirk J. Blom et al. Orphanet Journal of Rare Diseases
- Clinical, demographic and genetic characteristics of homozygous familial hypercholesterolemia patients worldwide: Interim results from the hofh international clinical collaborators (HICC) registry
- (2018) M. Hartgers et al. ATHEROSCLEROSIS
- Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study
- (2018) Atsushi Nohara et al. Journal of Atherosclerosis and Thrombosis
- Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
- (2017) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs
- (2017) Claudia Stefanutti et al. Journal of Clinical Lipidology
- The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
- (2017) Robert Leipold et al. European Journal of Preventive Cardiology
- Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
- (2017) Frederick J Raal et al. Lancet Diabetes & Endocrinology
- Limitations of cholesterol lowering with PCSK9 inhibitors
- (2017) Gilbert Thompson Lancet Diabetes & Endocrinology
- Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
- (2016) Stephan Krähenbühl et al. DRUGS
- MTP Gene Variants and Response to Lomitapide in Patients with Homozygous Familial Hypercholesterolemia
- (2016) Genovefa D Kolovou et al. Journal of Atherosclerosis and Thrombosis
- Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis
- (2016) Claudia Stefanutti et al. Journal of Clinical Lipidology
- Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
- (2015) Abdullah Al-Ashwal et al. Current Vascular Pharmacology
- Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia
- (2015) Anna Raper et al. Journal of Clinical Lipidology
- Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide
- (2015) Jeanine Roeters van Lennep et al. Journal of Clinical Lipidology
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: Insights from a patient survey
- (2014) Eric Bruckert et al. ATHEROSCLEROSIS SUPPLEMENTS
- Lomitapide and Mipomersen
- (2014) Daniel J. Rader et al. CIRCULATION
- Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances
- (2014) Claudia Stefanutti et al. Current Atherosclerosis Reports
- Hypobetalipoproteinemia and abetalipoproteinemia
- (2014) Francine K. Welty CURRENT OPINION IN LIPIDOLOGY
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- (2012) Frederick J. Raal et al. ATHEROSCLEROSIS
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
- (2011) Frederick J. Raal et al. CIRCULATION
- Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia
- (2011) Claudia Stefanutti et al. CYTOKINE
- Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
- (2010) Gilbert R Thompson et al. CURRENT OPINION IN LIPIDOLOGY
- Efficacy criteria and cholesterol targets for LDL apheresis
- (2009) Gilbert R. Thompson et al. ATHEROSCLEROSIS
- Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels
- (2009) D. Steinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
- (2008) Lisa C. Hudgins et al. AMERICAN JOURNAL OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started